Roy, Brittany D.
Li, Jianheng
Lally, Cathy
Akerman, Sarah C.
Sullivan, Maria A.
Fratantonio, James
Flanders, William Dana
Wenten, Madé
Article History
Received: 14 October 2022
Accepted: 12 March 2024
First Online: 2 April 2024
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations. This study was based on data from the IBM® MarketScan® Research Databases, which are limited data sets where direct identifiers have been removed. As the study did not enrol patients and the data sets used are devoid of patient identifiable information, patient consent requirements are not applicable and the study was exempt from IRB review requirements, as per the Alkermes Observation Research Review and Approval Committee policy. The protocol was approved by the Alkermes Observation Research Review and Approval Committee.
: Not applicable.
: SCA and MW are employees of Alkermes, Inc., and may own stock/options in the company. BDR, MAS, and JF were employees of Alkermes, Inc., at the time of this research and may own stock/options in the company. JL, CL, and WDF are employees of Epidemiologic Research & Methods, which contracted with Alkermes, Inc., to access these data and complete these analyses.